mesalamine has been researched along with Ileal Diseases in 5 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Ileal Diseases: Pathological development in the ILEUM including the ILEOCECAL VALVE.
Excerpt | Relevance | Reference |
---|---|---|
"Endoscopic postoperative recurrences occur early after 'curative' surgery for Crohn's disease." | 2.68 | Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID). ( Belaiche, J; Cortot, A; Daurat, M; Dupas, JL; Faucheron, JL; Florent, C; Gendre, JP; Jacquet, N; Lerebours, E; Malafosse, M; Michot, F; Modigliani, R; Quandale, P; Rothman, N; Sahmound, T; Sarfaty, E; Soulé, JC; Valleur, P, 1996) |
"Furthermore, the ulcer has since maintained the scar stage despite successfully weaning the patient from PSL." | 1.48 | Effects of the Concomitant Use of Low-dose Clarithromycin with an Anti-TNFα Antibody in a Patient with Intestinal Behçet Disease. ( Hirayama, T; Honda, A; Ikegami, T; Iwamoto, J; Konishi, N; Matsuzaki, Y; Monma, T; Murakami, M; Ueda, H; Yara, S, 2018) |
"We report a case of Crohn's disease in a 32-year old Saudi male." | 1.31 | Crohn's disease presenting as life-threatening ileal bleeding. ( Ahmad, TM; Al-Been, H; De Keersmaecker, J; Tysk, C, 2000) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Iwamoto, J | 1 |
Murakami, M | 1 |
Konishi, N | 1 |
Monma, T | 1 |
Ueda, H | 1 |
Yara, S | 1 |
Hirayama, T | 1 |
Ikegami, T | 1 |
Honda, A | 1 |
Matsuzaki, Y | 1 |
Otley, A | 1 |
LeLeiko, N | 1 |
Langton, C | 1 |
Lerer, T | 1 |
Mack, D | 1 |
Evans, J | 1 |
Pfefferkorn, M | 1 |
Carvalho, R | 1 |
Rosh, J | 1 |
Griffiths, A | 1 |
Oliva-Hemker, M | 1 |
Kay, M | 1 |
Bousvaros, A | 1 |
Stephens, M | 1 |
Samson, C | 1 |
Grossman, A | 1 |
Keljo, D | 1 |
Markowitz, J | 1 |
Hyams, J | 1 |
Florent, C | 1 |
Cortot, A | 1 |
Quandale, P | 1 |
Sahmound, T | 1 |
Modigliani, R | 1 |
Sarfaty, E | 1 |
Valleur, P | 1 |
Dupas, JL | 1 |
Daurat, M | 1 |
Faucheron, JL | 1 |
Lerebours, E | 1 |
Michot, F | 1 |
Belaiche, J | 1 |
Jacquet, N | 1 |
Soulé, JC | 1 |
Rothman, N | 1 |
Gendre, JP | 1 |
Malafosse, M | 1 |
Tysk, C | 1 |
De Keersmaecker, J | 1 |
Al-Been, H | 1 |
Ahmad, TM | 1 |
Ward, VM | 1 |
Dua, S | 1 |
Morrison, GA | 1 |
1 trial available for mesalamine and Ileal Diseases
Article | Year |
---|---|
Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID).
Topics: Administration, Oral; Adolescent; Adult; Aged; Aminosalicylic Acids; Anastomosis, Surgical; Anti-Inf | 1996 |
4 other studies available for mesalamine and Ileal Diseases
Article | Year |
---|---|
Effects of the Concomitant Use of Low-dose Clarithromycin with an Anti-TNFα Antibody in a Patient with Intestinal Behçet Disease.
Topics: Adalimumab; Aged; Anti-Inflammatory Agents; Behcet Syndrome; Cecal Diseases; Clarithromycin; Drug Th | 2018 |
Budesonide use in pediatric Crohn disease.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Budesonide; Child; Colon; Colo | 2012 |
Crohn's disease presenting as life-threatening ileal bleeding.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Colectomy; Colonic Diseases; Critical Illnes | 2000 |
Oro-facial granulomatosis: a laryngeal presentation.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Colonic Diseases; Female; Granuloma, Laryngeal; Huma | 2001 |